Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 1—January 2005

Research

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Edward A. Belongia*Comments to Author , Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
Author affiliations: *Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Wisconsin Division of Public Health, Madison, Wisconsin, USA; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 2

A) Retail distribution of fluoroquinolone antimicrobial agents, January 1999 through December 2002. Volume was measured in kilograms. B) Actual and predicted retail distribution of fluoroquinolone antimicrobial agents as a percentage of total antibiotic volume distribution (excluding tetracyclines), January 1999 through December 2002. Vertical bars show 95% confidence intervals.

Figure 2. A) Retail distribution of fluoroquinolone antimicrobial agents, January 1999 through December 2002. Volume was measured in kilograms. B) Actual and predicted retail distribution of fluoroquinolone antimicrobial agents as a percentage of total antibiotic volume distribution (excluding tetracyclines), January 1999 through December 2002. Vertical bars show 95% confidence intervals.

Main Article

TOP